medigraphic.com
Revista Médica Sinergia

2023, Número 04

<< Anterior Siguiente >>

Revista Médica Sinergia 2023; 8 (04)


Causas poco frecuentes de amenorrea debida a hipogonadismo hipogonadotrópico

Castro FM, Gamboa MS, Guevara SMF

Idioma: Español
Referencias bibliográficas: 31
Paginas:
Archivo PDF: 192.92 Kb.


RESUMEN

El hipogonadismo hipogonadotrópico es un síndrome clínico de diversas etiologías congénitas o adquiridas, las cuales pueden o no causar amenorrea, ya sea primaria o secundaria, entre otros trastornos de la pubertad. La clasificación del hipogonadismo hipogonadotrópico abarca múltiples patologías que tienen en común una anormalidad en el eje hipotálamo-hipofisario que lleva a una poca o nula estimulación ovárica.
Entre las causas congénitas poco comunes se encuentran el síndrome de Kallman, las causas idiopáticas de las cuales se han ido reconociendo mutaciones puntuales como la del CHD7, las mutaciones en la subunidad beta de la hormona foliculoestimulante y la hormona luteinizante; y del receptor de la hormona liberadora de gonadotropina. Respecto a las causas adquiridas poco comunes de amenorrea por hipogonadismo hipogonadotrópico se encuentran la seudociesis, la hipofisitis linfocítica periparto, la enfermedad hepática crónica no alcohólica y la enfermedad renal crónica.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Miller WL. The Hypothalamic-Pituitary-Adrenal Axis: A Brief History. Horm ResPaediatr. 2018;89(4):212-223. DOI: 10.1159/000487755. Epub 2018, May 2.PMID: 29719288.

  2. Sugiarto AM, Soelistijo SA. A female with isolated hypogonadotropic hypogonadism: A case report and review article. Ann Med Surg(Lond). 2022, Jan 26;74:103289. DOI: 10.1016/j.amsu.2022.103289. PMID: 35145667; PMCID: PMC8818903.

  3. Roberts RE, Farahani L, Webber L, JayasenaC. Current understanding of hypothalamic amenorrhoea. Ther Adv Endocrinol Metab.2020, Jul 30;11:2042018820945854. DOI: 10.1177/2042018820945854. PMID: 32843957; PMCID: PMC7418467.

  4. Kaur J, Walia R, Jain V, Bhansali A, Vatsa R,Siwatch S. Clinical indicators to define etiology in patients with primary amenorrhea:Lessons from a decade of experience. J Family Med Prim Care. 2020, Aug25;9(8):3986-3990. DOI:10.4103/jfmpc.jfmpc_85_20. PMID: 33110798; PMCID: PMC7586622.

  5. Hoffman BL, Schorge JO, Halvorson LM,Hamid CA, Corton MM, Schaffer JI. Williams Gynecology. 4th edition, United States ofAmerica: McGraw-Hill Education, 2020.Section 2, chapter 17: Amenorrhea. Available from: https://accessmedicine.mhmedical.com/book.aspx?bookid=265

  6. Smedlund KB, Hill JW. The role of nonneuronal cells in hypogonadotropic hypogonadism. Mol Cell Endocrinol. 2020,Dec 01;518:110996. DOI: 10.1016/j.mce.2020.110996. Epub 2020 Aug26. PMID: 32860862.

  7. Thakker S, Persily J, Najari BB. Kallmansyndrome and central non-obstructive azoospermia. Best Pract Res Clin EndocrinolMetab. 2020, Dec;34(6):101475. DOI:10.1016/j.beem.2020.101475. Epub 2020Dec 1. PMID: 33419659.

  8. Stamou MI, Georgopoulos NA. Kallmannsyndrome: phenotype and genotype ofhypogonadotropic hypogonadism.Metabolism. 2018, Sep;86:124-134. DOI: 10.1016/j.metabol.2017.10.012. Epub 2017,Nov 3. PMID: 29108899; PMCID: PMC5934335.

  9. Cangiano B, Swee DS, Quinton R, Bonomi M.Genetics of congenital hypogonadotropichypogonadism: peculiarities and phenotype ofan oligogenic disease. Hum Genet. 2021,Jan;140(1):77-111. DOI: 10.1007/s00439-020-02147-1. Epub 2020, Mar 21. PMID: 32200437.

  10. Viswanathan V, Eugster EA. Etiology andtreatment of hypogonadism in adolescents. Pediatr Clin North Am. 2011, Oct;58(5):1181-200. DOI: 10.1016/j.pcl.2011.07.009. PMID: 21981955; PMCID: PMC4102132.

  11. Nagdive AB, Bhainsora RS, Fernandes R,Behere PB, Sethi S. Pseudocyesis Leading toFolie-à-Deux. J Neurosci Rural Pract. 2021,Apr;12(2):419-423. DOI: 10.1055/s-0041-1726615. Epub 2021, Mar 24. PMID: 33927534; PMCID: PMC8064852.

  12. Espiridion ED, Fleckenstein C, Boyle P,Oladunjoye AO. A Rare Case ofPseudocyesis in a Patient with Bipolar Disorder. Cureus. 2020, Sep10;12(9):e10352. DOI:10.7759/cureus.10352. PMID: 33062475; PMCID: PMC7549847.

  13. Szeliga A, Kunicki M, Maciejewska-Jeske M,Rzewuska N, Kostrzak A, Meczekalski B, BalaG, Smolarczyk R, Adashi EY. The Genetic Backdrop of HypogonadotropicHypogonadism. Int J Mol Sci. 2021, Dec 08;22(24):13241. DOI:10.3390/ijms222413241. PMID: 34948037; PMCID: PMC8708611.

  14. Szymańska K, Kałafut J, Rivero-Müller A. Thegonadotropin system, lessons from animalmodels and clinical cases. Minerva Ginecol. 2018, Oct;70(5):561-587. DOI: 10.23736/S0026-4784.18.04307-1. Epub2018, Sep 26. PMID: 30264954.

  15. Song JW, Hwang HJ, Lee CM, Park GH, KimCS, Lee SJ, Ihm SH. Hypogonadotrophichypogonadism due to a mutation in theluteinizing hormone β-subunit gene. Korean J Intern Med. 2018, May;33(3):638-641. DOI: 10.3904/kjim.2015.373. Epub 2017, Jan 16.PMID: 28092701; PMCID: PMC5943644.

  16. Misgar RA, Wani AI, Bankura B, Bashir MI,Roy A, Das M. FSH β-subunit mutations in two sisters: the first report from the Indian sub-continent and review of previous cases. Gynecol Endocrinol. 2019, Apr;35(4):290-293. DOI: 10.1080/09513590.2018.1529159.Epub 2019, Jan 2. PMID: 30602350.

  17. Zhu L, Xiao N, Zhang T, Kong P, Xu B, FangZ, Jin L. Clinical and genetic analysis of anisolated follicle-stimulating hormone deficiency female patient. J Assist Reprod Genet. 2020, Jun;37(6):1441-1448. DOI: 10.1007/s10815-020-01786-7. Epub 2020,May 5. PMID: 32367462; PMCID: PMC7311626.

  18. Lee G, Lee MS, Lee R, Moon JE. A novelcompound variant in GNRHR causing congenital idiopathic hypogonadotropic hypogonadism in a young male Koreanpatient. Ann Pediatr Endocrinol Metab. 2022,Jun 30. DOI: 10.6065/apem.2244070.035.Epub ahead of print. PMID: 35798295.

  19. Cioppi F, Riera-Escamilla A, Manilall A,Guarducci E, Todisco T, Corona G, Colombo F, Bonomi M, Flanagan CA, Krausz C.Genetics of ncHH: from a peculiar inheritance of a novel GNRHR mutation to a comprehensive review of the literature. Andrology. 2019, Jan;7(1):88-101. DOI: 10.1111/andr.12563. Epub 2018, Dec 21.PMID: 30575316.

  20. Rivero-Müller A, Huhtaniemi I. Genetic variants of gonadotrophins and their receptors: Impact on the diagnosis andmanagement of the infertile patient. BestPract Res Clin Endocrinol Metab. 2022,Jan;36(1):101596. DOI:10.1016/j.beem.2021.101596. Epub 2021,Nov 10. PMID: 34802912.

  21. Wang L, Lin W, Li X, Zhang L, Wang K, Cui X,Tang S, Fang G, Tan Y, Wang X, Chen C,Yang C, Tang H. A case report of congenital idiopathic hypogonadotropic hypogonadismcaused by novel mutation of GNRHR gene.Medicine (Baltimore). 2021, Feb5;100(5):e24007. DOI:10.1097/MD.0000000000024007. PMID: 33592857; PMCID: PMC7870162.

  22. Maione L, Fèvre A, Nettore IC, Manilall A,Francou B, Trabado S, Bouligand J,Guiochon-Mantel A, Delemer B, FlanaganCA, Macchia PE, Millar RP, Young J. Similarities and differences in the reproductive phenotypes of women with congenitalhypogonadotrophic hypogonadism caused byGNRHR mutations and women with polycystic ovary syndrome. Hum Reprod. 2019, Jan 01;34(1):137-147. DOI: 10.1093/humrep/dey339. PMID: 30476149.

  23. Šmigoc Schweiger D, Davidović Povše M,Trebušak Podkrajšek K, Battelino T, Avbelj Stefanija M. GNRHR-related centralhypogonadism with spontaneous recovery - case report. Ital J Pediatr. 2022, Nov 12;48(1):184. DOI: 10.1186/s13052-022-01377-5. PMID: 36371229; PMCID: PMC9652797.

  24. Funazaki S, Yamada H, Hara K, Ishikawa SE.Spontaneous pregnancy after full recoveryfrom hypopituitarism caused by lymphocytic hypophysitis. Endocrinol Diabetes Metab Case Rep. 2018, Aug 03;2018:18-0081. DOI: 10.1530/EDM-18-0081. PMID: 30083350;PMCID: PMC6075371.

  25. Nana M, Williamson C. Pituitary and Adrenal Disorders of Pregnancy. 2022, Oct 11. In:Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Hofland J, Dungan K,Hofland J, Kalra S, Kaltsas G, Kapoor N, KochC, Kopp P, Korbonits M, Kovacs CS, KuohungW, Laferrère B, Levy M, McGee EA,McLachlan R, New M, Purnell J, Sahay R,Singer F, Sperling MA, Stratakis CA, TrenceDL, Wilson DP, editors. Endotext [Internet].South Dartmouth (MA): MDText.com, Inc.; 2000–. PMID: 25905272. Available from: https://pubmed.ncbi.nlm.nih.gov/25905272/

  26. Honegger J, Giese S. Acute pituitary disease in pregnancy: how to handle hypophysitis andSheehan's syndrome. Minerva Endocrinol. 2018, Dec;43(4):465-475. DOI: 10.23736/S0391-1977.18.02814-6. Epub2018, Feb 19. PMID: 29463076.

  27. Takaki Y, Mizuochi T, Nishioka J, Eda K,Yatsuga S, Yamashita Y. Nonalcoholic fatty liver disease with prolactin-secreting pituitary adenoma in an adolescent: A case report.Medicine (Baltimore). 2018,Oct;97(42):e12879. DOI:10.1097/MD.0000000000012879. PMID: 30335007; PMCID: PMC6211884.

  28. 28.Barber TM, Kyrou I, Kaltsas G, Grossman AB,Randeva HS, Weickert MO. Mechanisms ofCentral Hypogonadism. Int J Mol Sci. 2021,Jul 30;22(15):8217. DOI: 10.3390/ijms22158217. PMID: 34360982; PMCID: PMC8348115.

  29. Cundy TF, Butler J, Pope RM, Saggar-MalikAK, Wheeler MJ, Williams R. Amenorrhoea inwomen with non-alcoholic chronic liver disease. Gut. 1991, Feb;32(2):202-6. DOI: 10.1136/gut.32.2.202. PMID: 1864542;PMCID: PMC1378809.

  30. Rojas R, Clegg DJ, Palmer BF. Amenorrheaand Estrogen Disorders in Kidney Disease. Semin Nephrol. 2021, Mar;41(2):126-132.DOI: 10.1016/j.semnephrol.2021.03.007.PMID: 34140091.

  31. Chang DH, Dumanski SM, Ahmed SB.Female Reproductive and Gynecologic Considerations in Chronic Kidney Disease: Adolescence and Young Adulthood. Kidney Int Rep. 2021, Nov 25;7(2):152-164. DOI: 10.1016/j.ekir.2021.11.003. PMID: 35155855;PMCID: PMC8820991.




2020     |     www.medigraphic.com